TRAX compared with ANAB: revenue, margins and what each company keeps, and the suppliers and customers both name

TRAXFirst Tracks Biotherapeutics, Inc.

Mkt capRevenueRevenue

ANABAnaptysbio, Inc

Mkt capRevenueRevenue

Compare

TRAXFirst Tracks Biotherapeutics, Inc.

ANABAnaptysbio, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TRAX 1

—Centessa Pharmaceuticals (UK)unlistedsupplier

Shared 0

No shared counterparties.

Only ANAB 4

VNDAVanda Pharmaceuticalscustomer

GSKGSKcustomer

—DRI Healthcare Trustunlistedsupplier

—Sagard Healthcare Royalty Partners

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

TRAXFirst Tracks Biotherapeutics, Inc.

45.86▲+1.80%

Mkt cap$1.6BRevenue—Revenue—

ANABAnaptysbio, Inc

47.87▲+2.05%

Regular sessionNov 3 '26

Mkt cap$1.4BRevenue$26MQ1 FY26Revenue$235MFY25

Compare

Regular sessionNov 3 '26

TRAXFirst Tracks Biotherapeutics, Inc.

ANABAnaptysbio, Inc

45.86▲+1.80%

Price

47.87▲+2.05%

$1.6B

Mkt cap

$1.4B

—

Revenue

$26MQ1 FY26

—

Revenue

$235MFY25

TRAX45.86▲+1.80%vsANAB47.87▲+2.05%Regular sessionNov 3 '26